Literature DB >> 25344588

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.

Ville T Männistö1, Marko Simonen1, Pasi Soininen2, Mika Tiainen3, Antti J Kangas4, Dorota Kaminska5, Sari Venesmaa6, Pirjo Käkelä6, Vesa Kärjä7, Helena Gylling8, Mika Ala-Korpela9, Jussi Pihlajamäki10.   

Abstract

Nonalcoholic steatohepatitis (NASH) is associated with increased synthesis of triglycerides and cholesterol coupled with increased VLDL synthesis in the liver. In addition, increased cholesterol content in the liver associates with NASH. Here we study the association of lipoprotein subclass metabolism with NASH. To this aim, liver biopsies from 116 morbidly obese individuals [age 47.3 ± 8.7 (mean ± SD) years, BMI 45.1 ± 6.1 kg/m², 39 men and 77 women] were used for histological assessment. Proton NMR spectroscopy was used to measure lipid concentrations of 14 lipoprotein subclasses in native serum samples at baseline and after obesity surgery. We observed that total lipid concentration of VLDL and LDL subclasses, but not HDL subclasses, associated with NASH [false discovery rate (FDR) < 0.1]. More specifically, total lipid and cholesterol concentration of VLDL and LDL subclasses associated with inflammation, fibrosis, and cell injury (FDR < 0.1), independent of steatosis. Cholesterol concentration of all VLDL subclasses also correlated with total and free cholesterol content in the liver. All NASH-related changes in lipoprotein subclasses were reversed by obesity surgery. High total lipid and cholesterol concentration of serum VLDL and LDL subclasses are linked to cholesterol accumulation in the liver and to liver cell injury in NASH.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  high density lipoprotein; lipids; lipoproteins/metabolism; liver; low density lipoprotein; nuclear magnetic resonance; obesity; obesity surgery; very low density lipoprotein

Mesh:

Substances:

Year:  2014        PMID: 25344588      PMCID: PMC4242459          DOI: 10.1194/jlr.P054387

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  44 in total

1.  Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women".

Authors:  Mika Ala-Korpela; Pasi Soininen; Markku J Savolainen
Journal:  Circulation       Date:  2009-10-27       Impact factor: 29.690

2.  Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway.

Authors:  P M Yao; I Tabas
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

3.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

4.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 5.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 6.  Non-alcoholic fatty liver disease from pathogenesis to management: an update.

Authors:  G Musso; R Gambino; M Cassader
Journal:  Obes Rev       Date:  2009-10-21       Impact factor: 9.213

7.  Liver fat in the metabolic syndrome.

Authors:  Anna Kotronen; Jukka Westerbacka; Robert Bergholm; Kirsi H Pietiläinen; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

8.  A lipidomic analysis of nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Rebecca A Baillie; Michelle M Wiest; Faridoddin Mirshahi; Jayanta Choudhury; Onpan Cheung; Carol Sargeant; Melissa J Contos; Arun J Sanyal
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 9.  Fatty liver: a novel component of the metabolic syndrome.

Authors:  Anna Kotronen; Hannele Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-09       Impact factor: 8.311

10.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

View more
  25 in total

Review 1.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

2.  Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action.

Authors:  Vanessa D de Mello; Ashok Matte; Alexander Perfilyev; Ville Männistö; Tina Rönn; Emma Nilsson; Pirjo Käkelä; Charlotte Ling; Jussi Pihlajamäki
Journal:  Epigenetics       Date:  2017-02-23       Impact factor: 4.528

3.  Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.

Authors:  Kathleen E Corey; Laura A Wilson; Akif Altinbas; Katherine P Yates; David E Kleiner; Raymond T Chung; Ronald M Krauss; Naga Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2019-03-10       Impact factor: 8.171

4.  Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.

Authors:  Zhenghui G Jiang; Elliot B Tapper; Misung Kim; Margery A Connelly; Sarah A Krawczyk; Eric U Yee; Mark A Herman; Kenneth J Mukamal; Michelle Lai
Journal:  J Clin Gastroenterol       Date:  2018 May/Jun       Impact factor: 3.062

5.  TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.

Authors:  Giovanni Musso; Ugo Cipolla; Maurizio Cassader; Silvia Pinach; Francesca Saba; Franco De Michieli; Elena Paschetta; Daria Bongiovanni; Luciana Framarin; Nicola Leone; Mara Berrutti; Floriano Rosina; Stefania Corvisieri; Federica Molinaro; Antonio Sircana; Roberto Gambino
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

6.  Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.

Authors:  Z Gordon Jiang; Ian H de Boer; Rachel H Mackey; Majken K Jensen; Michelle Lai; Simon C Robson; Russell Tracy; Lewis H Kuller; Kenneth J Mukamal
Journal:  Metabolism       Date:  2015-10-22       Impact factor: 8.694

7.  Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.

Authors:  Emma Nilsson; Ashok Matte; Alexander Perfilyev; Vanessa D de Mello; Pirjo Käkelä; Jussi Pihlajamäki; Charlotte Ling
Journal:  J Clin Endocrinol Metab       Date:  2015-09-29       Impact factor: 5.958

8.  FADS2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissue.

Authors:  Maija Vaittinen; Paula Walle; Emmi Kuosmanen; Ville Männistö; Pirjo Käkelä; Jyrki Ågren; Ursula Schwab; Jussi Pihlajamäki
Journal:  J Lipid Res       Date:  2015-11-25       Impact factor: 5.922

9.  Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.

Authors:  Zhenghui G Jiang; Elliot B Tapper; Margery A Connelly; Carolina F M G Pimentel; Linda Feldbrügge; Misung Kim; Sarah Krawczyk; Nezam Afdhal; Simon C Robson; Mark A Herman; James D Otvos; Kenneth J Mukamal; Michelle Lai
Journal:  Liver Int       Date:  2016-02-24       Impact factor: 5.828

10.  Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.

Authors:  Anna E Garcia; Nader Kasim; Robyn A Tamboli; Raul S Gonzalez; Joseph Antoun; Emily A Eckert; Pamela A Marks-Shulman; Julia Dunn; Julia Wattacheril; Taylor Wallen; Naji N Abumrad; Charles Robb Flynn
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.